Cargando…
Invasive paediatric Elizabethkingia meningoseptica infections are best treated with a combination of piperacillin/tazobactam and trimethoprim/sulfamethoxazole or fluoroquinolone
OBJECTIVES: Elizabethkingia meningoseptica is a multi-drug-resistant organism that is associated with high mortality and morbidity in newborn and immunocompromised patients. This study aimed to identify the best antimicrobial therapy for treating this infection. METHODS: A retrospective descriptive...
Autores principales: | Chan, J. C., Chong, C. Y., Thoon, K. C., Tee, N. W. S., Maiwald, M., Lam, J. C. M., Bhattacharya, R., Chandran, S., Yung, C. F., Tan, N. W. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423161/ https://www.ncbi.nlm.nih.gov/pubmed/31199227 http://dx.doi.org/10.1099/jmm.0.001021 |
Ejemplares similares
-
Bacteremia due to Elizabethkingia meningoseptica
por: Shinha, Takashi, et al.
Publicado: (2015) -
Draft Genome Sequences of Elizabethkingia meningoseptica
por: Matyi, Stephanie A., et al.
Publicado: (2013) -
Diagnostic Pitfalls in Identification of Elizabethkingia Meningoseptica
por: Rahim, Gurmeet Ram, et al.
Publicado: (2018) -
Comparison of Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Elizabethkingia meningoseptica and Elizabethkingia anophelis Isolated in Taiwan
por: Lin, Jiun-Nong, et al.
Publicado: (2018) -
Elizabethkingia Intra-Abdominal Infection and Related Trimethoprim-Sulfamethoxazole Resistance: A Clinical-Genomic Study
por: Teng, Ling-Chiao, et al.
Publicado: (2021)